Shirabe Ken, Itoh Shinji, Yoshizumi Tomoharu, Soejima Yuji, Taketomi Akinobu, Aishima Shin-Ichi, Maehara Yoshihiko
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
J Surg Oncol. 2007 Mar 1;95(3):235-40. doi: 10.1002/jso.20655.
The microvascular invasion of cancer cells (mvi) is a good prognostic factor after orthotopic liver transplantation (OLT) for hepatocellular carcinoma (HCC). The aim of this study is to predict mvi in patients with HCC who were candidates for OLT. We studied 218 patients with HCC resections who had HCC without any extrahepatic metastases and vascular invasion detected during preoperative evaluation. We analyzed the clinico-pathological data of these patients to predict the mvi presence. The mvi prediction scoring system was made and the accuracy of this system was examined using independent clinico-pathologic factors. The size and histological grade of the tumor were significantly correlated with the mvi. The des-gamma-carboxy prothrombin (DCP) is a mvi predictor. The sensitivity of our mvi prediction system was 75% and the specificity was 85% in 32 patients who underwent living-donor liver transplantations for HCC. Our study shows that besides the tumor size and histological grade, a measurement of the serum DCP levels could be a good predictor for mvi. A tumor biopsy and a preoperative measurement of DCP could improve the selection of patients with HCC for OLT. Our scoring system for mvi provides us a precise prediction of the presence of mvi.
癌细胞微血管侵犯(MVI)是肝细胞癌(HCC)原位肝移植(OLT)术后的一个良好预后因素。本研究的目的是预测OLT候选患者中HCC的MVI情况。我们研究了218例接受HCC切除术的患者,这些患者在术前评估中未发现任何肝外转移和血管侵犯。我们分析了这些患者的临床病理数据以预测MVI的存在。制定了MVI预测评分系统,并使用独立的临床病理因素检验了该系统的准确性。肿瘤大小和组织学分级与MVI显著相关。去γ-羧基凝血酶原(DCP)是MVI的一个预测指标。在32例因HCC接受活体肝移植的患者中,我们的MVI预测系统的敏感性为75%,特异性为85%。我们的研究表明,除肿瘤大小和组织学分级外,血清DCP水平的检测可能是MVI的一个良好预测指标。肿瘤活检和术前DCP检测可改善HCC患者OLT的选择。我们的MVI评分系统为我们提供了对MVI存在情况的精确预测。